Compositions and methods for boosting the efficacy of adoptive cellular immunotherapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10828352
APP PUB NO 20170246279A1
SERIAL NO

15521794

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides compositions and methods for boosting, augmenting or enhancing the efficacy of the adoptive cellular immunotherapy by using modified T cells expressing an antigen binding protein in conjunction with modified cells (such as hematopoietic progenitor cells, modified human immune system cells or a combination thereof) expressing the antigen specifically bound by the antigen binding protein of the modified T cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FRED HUTCHINSON CANCER CENTER1100 FAIRVIEW AVENUE NORTH SEATTLE WA 98109

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berger, Susanna Carolina Seattle, US 4 16
Riddell, Stanley R Sammamish, US 50 680

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 10, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 10, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00